Literature DB >> 21593505

Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study.

Diana P Brostow1, Andrew O Odegaard, Woon-Puay Koh, Sue Duval, Myron D Gross, Jian-Min Yuan, Mark A Pereira.   

Abstract

BACKGROUND: The role of omega-3 (n-3) fatty acids (FAs) in the development of type 2 diabetes is uncertain, especially with regard to any differential influence of α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
OBJECTIVE: The objective was to examine the association between total omega-3 FAs, marine omega-3 (EPA, DHA), nonmarine omega-3 (ALA), and omega-6 (n-6) FAs and omega-6:omega-3 ratio and risk of type 2 diabetes in a Chinese population in Singapore.
DESIGN: The analysis included 43,176 Chinese men and women free of chronic disease, aged 45-74 y, in the Singapore Chinese Health Study. Baseline data collection occurred between 1993 and 1998, with follow-up interviews between 1999 and 2004. Cox regression models were used to examine the associations between FA intakes at baseline and risk of developing diabetes.
RESULTS: Increased intakes of total omega-3 FAs were inversely associated with diabetes incidence [hazard ratio (HR) for the fifth compared with the first quintile: 0.78; 95% CI: 0.65, 0.94; P for trend = 0.02]. Omega-3 FAs from marine sources were not associated with diabetes risk, whereas nonmarine omega-3 FA intake was strongly associated (HR for the fifth compared with the first quintile: 0.79; 95% CI: 0.67, 0.93; P for trend = 0.004). Omega-6 and omega-6:omega-3 ratio were not associated with incidence of type 2 diabetes.
CONCLUSION: Consumption of nonmarine sources (ALA) of omega-3 FAs is associated with a decreased risk of type 2 diabetes in Chinese Singaporeans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593505      PMCID: PMC3142726          DOI: 10.3945/ajcn.110.009357

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  44 in total

1.  Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.

Authors:  Vikkie A Mustad; Stephen Demichele; Yung-Sheng Huang; Amanda Mika; Nathan Lubbers; Nathalie Berthiaume; Jim Polakowski; Brad Zinker
Journal:  Metabolism       Date:  2006-10       Impact factor: 8.694

Review 2.  Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease.

Authors:  William S Harris; Basel Assaad; W Carlos Poston
Journal:  Am J Cardiol       Date:  2006-05-30       Impact factor: 2.778

3.  Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.

Authors:  A Seow; C Y Shi; A A Franke; J H Hankin; H P Lee; M C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-02       Impact factor: 4.254

4.  Diabetes is related to fatty acid imbalance in Eskimos.

Authors:  S O Ebbesson; J Kennish; L Ebbesson; O Go; J Yeh
Journal:  Int J Circumpolar Health       Date:  1999-04       Impact factor: 1.228

5.  Dietary patterns, meat intake, and the risk of type 2 diabetes in women.

Authors:  Teresa T Fung; Matthias Schulze; JoAnn E Manson; Walter C Willett; Frank B Hu
Journal:  Arch Intern Med       Date:  2004-11-08

6.  Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

Authors:  Rosalba Giacco; Vincenzo Cuomo; Bengt Vessby; Matti Uusitupa; Kjeld Hermansen; Barbara J Meyer; Gabriele Riccardi; Angela A Rivellese
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-11-28       Impact factor: 4.222

7.  The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters.

Authors:  B Vessby; A Aro; E Skarfors; L Berglund; I Salminen; H Lithell
Journal:  Diabetes       Date:  1994-11       Impact factor: 9.461

8.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids.

Authors:  M Borkman; L H Storlien; D A Pan; A B Jenkins; D J Chisholm; L V Campbell
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

9.  Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes.

Authors:  A Seow; C Y Shi; F L Chung; D Jiao; J H Hankin; H P Lee; G A Coetzee; M C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-09       Impact factor: 4.254

10.  Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.

Authors:  I Toft; K H Bønaa; O C Ingebretsen; A Nordøy; T Jenssen
Journal:  Ann Intern Med       Date:  1995-12-15       Impact factor: 25.391

View more
  31 in total

Review 1.  Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.

Authors:  Akintunde O Akinkuolie; Julius S Ngwa; James B Meigs; Luc Djoussé
Journal:  Clin Nutr       Date:  2011-09-29       Impact factor: 7.324

Review 2.  Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis.

Authors:  Jason H Y Wu; Renata Micha; Fumiaki Imamura; An Pan; Mary L Biggs; Owais Ajaz; Luc Djousse; Frank B Hu; Dariush Mozaffarian
Journal:  Br J Nutr       Date:  2012-06       Impact factor: 3.718

Review 3.  The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies.

Authors:  T Hu; L A Bazzano
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-01-02       Impact factor: 4.222

4.  Plasma and Dietary Linoleic Acid and 3-Year Risk of Type 2 Diabetes After Myocardial Infarction: A Prospective Analysis in the Alpha Omega Cohort.

Authors:  Kamalita Pertiwi; Anne J Wanders; Marjolein C Harbers; Leanne K Küpers; Sabita S Soedamah-Muthu; Janette de Goede; Peter L Zock; Johanna M Geleijnse
Journal:  Diabetes Care       Date:  2019-11-14       Impact factor: 19.112

5.  Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial.

Authors:  Feng Wang; Yanyan Wang; Yan Zhu; Xiaosong Liu; Hui Xia; Xian Yang; Guiju Sun
Journal:  Eur J Nutr       Date:  2016-12-02       Impact factor: 5.614

6.  Genome-wide meta-analyses identify novel loci associated with n-3 and n-6 polyunsaturated fatty acid levels in Chinese and European-ancestry populations.

Authors:  Yao Hu; Huaixing Li; Ling Lu; Ani Manichaikul; Jingwen Zhu; Yii-Der I Chen; Liang Sun; Shuang Liang; David S Siscovick; Lyn M Steffen; Michael Y Tsai; Stephen S Rich; Rozenn N Lemaitre; Xu Lin
Journal:  Hum Mol Genet       Date:  2016-01-06       Impact factor: 6.150

7.  Dietary fat quality in regular fat diets has minor effects on biomarkers of inflammation in obese Zucker rats.

Authors:  Daniela Graf; Stephan W Barth; Achim Bub; Judith Narr; Corinna E Rüfer; Bernhard Watzl; Stephanie Seifert
Journal:  Eur J Nutr       Date:  2013-04-05       Impact factor: 5.614

Review 8.  Fatty acids and cardiometabolic health: a review of studies in Chinese populations.

Authors:  Liang Sun; Geng Zong; Huaixing Li; Xu Lin
Journal:  Eur J Clin Nutr       Date:  2020-08-14       Impact factor: 4.016

9.  A Dietary Pattern Derived from Reduced Rank Regression and Fatty Acid Biomarkers Is Associated with Lower Risk of Type 2 Diabetes and Coronary Artery Disease in Chinese Adults.

Authors:  Jowy Y H Seah; Choon Nam Ong; Woon-Puay Koh; Jian-Min Yuan; Rob M van Dam
Journal:  J Nutr       Date:  2019-11-01       Impact factor: 4.798

10.  Cooking Oil Consumption Is Positively Associated with Risk of Type 2 Diabetes in a Chinese Nationwide Cohort Study.

Authors:  Pan Zhuang; Lei Mao; Fei Wu; Jun Wang; Jingjing Jiao; Yu Zhang
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.